SAGE Therapeutics, Inc. (SAGE)

60.83
1.90 3.30
NASDAQ
Prev Close 58.90
Open 59.06
Day Low/High 58.74 / 60.94
52 Wk Low/High 25.01 / 155.33
Volume 277.74K
Exchange NASDAQ
Shares Outstanding 51.97B
Market Cap 3.12B
P/E Ratio N/A
Div & Yield N.A. (N.A)

My Takeaways and Observations

Slow day, at meetings all morning.   Despite the strength in our currency (and its adverse implications on multi-national profitability), there was no follow-through to yesterday's schmeissing.   I reflected on my July call that we have hit a Genera...

Takeaways and Observations

The markets moved lower from the "get go," though about the time Sixty Minutes was on last evening the S&P 500 futures were up 10 handles. (Futures closed down 2.5 handles)   Perhaps this is the start of a well due correction. Apropos, here is the q...

My Takeaways and Observations

"Well, they call you lady luck But there is room for doubt At times you have a very un-lady-like way Of running out..." -- Guys and Dolls, Luck Be A Lady (Frank Sinatra)  Trump will not likely Make Twitter Great Again.   I, bear.    Explaining my pr...

My Takeaways and Observations

What a strange day -- maybe even ominous.   This table tells it all.    The divergences I have been mentioning this week intensified today, with the technology-laden Nasdaq taken out to the shed and the Russell 2000 Index trading lower for the third...

My Takeaways and Observations

The important messages today are the developing divergences.    The strength in energy stocks (reflecting a $3.88 a barrel rise in crude oil) masked the underlying weakness in the broader markets. Stated simply, these divergences in breadth, highs/l...

My Takeaways and Observations (3:30 p.m. Edition)

It may be time to embrace the contrary.    First issue (!!): The Palm Beach Chronicles.   My weekly (brief) technical review of the markets -- cooling off ahead?    BTIG's Stockton is bullish and so, as I have expressed, are most others!   Campbell ...

Retail, Financials, Speculative Biotechs Getting Hit

This morning I warned about an overbought group of market sectors/leaders.   Thus far, (recent leaders) retail and financials are being taken out to the woodshed.   Speculative biotech, like Intrexon  , Portola Pharmaceuticals  , SAGE Therapeutics  ...

The Good, the Bad and the Ugly

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly" The Good, the Bad and the Ugly" I further added to my short exposure today in a quiet, pre-Thanksgiving trading session. And now it's time to run down "The Good...

The Good, the Bad and the Ugly (2:30 PM Edition)

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...

My Takeaways and Observations

At the end of the day!    Don't run with the crowd: Embrace contrary and second-level thinking instead.    Extreme policy uncertainty.    More Howard Marks.    Less Bill Miller.    My little sister!    Graf wrote a goodie.    The movie was in revers...

My Takeaways and Observations

Donald Trump may make illiquidity, volatility and uncertainty great again.    More "Penneys" from heaven, an analysis of the company's quarterly release.    Trade of the Week -- short Apple . Here and here.    I sold my retail long rentals for sick ...

My Takeaways and Observations

"Today I am asking myself ... Did the FANG names just peak the way iShares NASDAQ Biotechnology Index ETF IBB did in 2015 and Energy Select Sector SPDR ETFXLE did in 2014? The S&P 500 Index kept rising, but those two groups were done!"  -- Kass Diar...

My Takeaways and Observations

"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax.   A consecutive nine-day market drop was snapped as we regained most that was lost in that period.   Today was a great day. (Boy, would I like to annualize the pe...

Some Potential Positives Today

Some potential positives today: Strength in the Russell Index. Improving breadth. Improving Clinton odds by "538" and the London betting parlors. A great deal of pushback to my idea of a trading rally. Turnaround in large-cap biotech (Allergan , Cel...

My Takeaways and Observations (Early Edition)

I have been warning about weakening breadth and narrow leadership for weeks and months.   What have we gotten? Eight straight days (in a row) down for the first time since 2008.   But, with stocks suffering from election uncertainties and given the ...

Biowreck!

I warned in yesterday's Good, Bad and Ugly against taking shots on speculative stocks like biotech. Well, the biotech space is getting pummeled today. For example, Sage Therapeutics is down 11.8% as I write this, while Acadia Pharmaceuticals is off ...

A SAGE Conclusion

Sage Therapeutics -- which was part of the speculative biotech basket that I bought a bit back but have since sold -- is soaring by more than 40% in premarket trading. SAGE is rallying on positive Phase II test results for its postpartum-depression ...

Takeaways and Observations

I was out of the office yesterday, but my take on the session is: "Up, Down, Up, Flat." It was a mixed day in terms of economic data, with potholes everywhere. (You'd have to be blind not to see them.) It was all about retail yet again, and it sure ...

My Takeaways and Observations

Today and yesterday are good examples of the fondness of crowds, and that buyers live higher and sellers live lower. Stocks closed at the day's highs, despite a reversal in the price of crude oil and some weak domestic data and disappointing retail ...

My Takeaways and Observations

"Wouldn't it be nice if we were older Then we wouldn't have to wait so long And wouldn't it be nice to live together In the kind of world where we belong..." --Beach Boys, "Wouldn't It Be Nice?"  I feel strongly that there is no or a limited safety ...

My Takeaways and Observations

Another strong market day.  The issue of taxes was front and center today. Here are some of my takes: My Take on Corporate Taxes  Man Up, Allergan Shareholders  Who Loses in Pfizer/Allergan Deal's Demise?  I remain manifestly bearish, in the belief ...

Today's Takeaways and Observations (Early Edition)

I started the day today by dissing the banks.                  Then, I unfriended Facebook (FB) by making it my Short Trade of the Week. Finally, I offered another critical post about auto stocks. Hey, at least I'm consistent! And at least I like Op...

Today's Takeaways and Observations (Early Edition)

I started the day with a cautionary tale (click here and here), then made Apple (AAPL) my Short Trade of a Week. I also made a hard decision to take all nine banks off of my "Best Long Ideas" list and sell off some of my bank holdings. My takeaways ...

Biotech Biowreck!

The collapse of Valeant Pharmaceuticals (VRX) has cast a pall over the entire biotech sector today. The iShares Nasdaq Biotechnology ETF (IBB) is down by about 3%, led by VRX plus significant drops in Allergan (AGN), Celgene (CELG) and Gilead Scienc...

My Takeaways and Observations

 "What came first? The chicken or the Ben?" --Tiara Soleim, talking about "The Bachelor's" Ben Higgins this season Final rose? The obvious and recurrence of price action from the past continues, but for how long? Maybe only The Shadow knows.  "Move ...

My Takeaways and Observations

Time flies -- it was seven years ago when I predicted The Generational Bottom.   I started the day with a refresher on my "Peak Autos" thesis.  In the middle of the day I underscored the appeal of Blackstone/GSO Strategic Credit Fund (BGB) and junk ...

My Takeaways and Observations

I remain "all in short," positioned on Friday afternoon.   My message for the day this morning? "Don't worship at the church of what's happening now."  The key insight today was the flight to safety. More risk off might lie ahead. Thanks for the nic...

My Takeaways and Observations

What a weekend at the First Annual RealMoneyPro Golf Tournament and Conference! Unprecedented fun!!  Here is why I am "all in" short.  I made some important portfolio changes today, selling six core long investments.  I am at my largest net short po...

My Takeaways and Observations

A win for the bulls. I outlined my cautious view in my opener.  I sold a number of longs and reduced my long side today.   I sold my biotech basket for a good two-and-a-half-week gain.  I reduced my bank longs from large to between small and medium ...

Selling Biotechs for Some Nice Gains

I'm reducing the size of my biotech basket by selling across the board following some very large gains. In fact, I expect to completely eliminate my holdings if we see any further increases. Today's gains have been truly breathtaking. We've seen 5% ...